2018
DOI: 10.1016/j.pcd.2017.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Impact of depression and/or anxiety on the presentation of cardiovascular events in a cohort with metabolic syndrome. StreX project: Five years of follow-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Bruce et al (2016) report an elevated risk of cardiovascular mortality, but not of incident CHD, for type 2 diabetes patients with GAD. In a Spanish study, anxiety was not significantly associated with an adverse cardiovascular event or mortality in a sample with metabolic syndrome (Ortega et al, 2018). Surveying a sample of female breast cancer survivors free of CVD in the Netherlands, Schoormans et al (2017) found a significant association of pharmaceutically treated anxiety and CVD.…”
Section: Prognostic Approaches To Anxiety and Cvdmentioning
confidence: 93%
“…Bruce et al (2016) report an elevated risk of cardiovascular mortality, but not of incident CHD, for type 2 diabetes patients with GAD. In a Spanish study, anxiety was not significantly associated with an adverse cardiovascular event or mortality in a sample with metabolic syndrome (Ortega et al, 2018). Surveying a sample of female breast cancer survivors free of CVD in the Netherlands, Schoormans et al (2017) found a significant association of pharmaceutically treated anxiety and CVD.…”
Section: Prognostic Approaches To Anxiety and Cvdmentioning
confidence: 93%
“…Depression is considered as one of the main leading cause of disability, increasing personal and community costs (3) . In particular, late-life depression negatively affects health outcomes specifically on cardiovascular disease (CVD) in adults with Metabolic Syndrome (MetS) (4) . Traditional treatments based on antidepressant drugs are not enough to counteract its burden, besides to enhancing a great cost to the health care system (5) .…”
Section: Introductionmentioning
confidence: 99%